Samsung Biologics, Foreign Investors Net Sell 38,412 Shares... Stock Price -2.8%
Samsung Biologics ranked among the top searched stocks for 13 days in the past month.
As of 1:30 PM on the 8th, Samsung Biologics is trading at 730,000 KRW, down 2.8% from the previous day. This represents an 11.62% decline compared to June 16. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners have sold a net 38,412 shares of Samsung Biologics, and institutions have sold a net 2,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 192,803 shares, while foreigners and institutions have sold a net 217,706 shares and bought a net 24,664 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Dramatic Agreement Reached on Eve of Samsung Electronics General Strike... Minister Kim Young-hoon: "Showcased Korea's Strength in Dialogue" (Update)
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Need to Discuss Excluding Controlling Shareholders' Voting Rights in Dual Listings"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
